{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T18:00:00Z","timestamp":1758045600804,"version":"3.44.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.amjms.2022.04.021","type":"journal-article","created":{"date-parts":[[2022,4,23]],"date-time":"2022-04-23T01:53:20Z","timestamp":1650678800000},"page":"386-393","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Challenges in diuretic therapy: A case-based discussion"],"prefix":"10.1016","volume":"364","author":[{"given":"Emmanuel A.","family":"Adomako","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamalanathan K.","family":"Sambandam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.amjms.2022.04.021_bib0001","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1172\/JCI103330","article-title":"Total body water and total exchangeable sodium in edematous states due to cardiac, renal or hepatic disease 1","volume":"35","author":"Farber","year":"1956","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.amjms.2022.04.021_bib0002","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1172\/JCI103655","article-title":"Total exchangeable sodium, total exchangeable potassium, and total body water in edematous patients with cirrhosis of the liver and congestive heart failure","volume":"37","author":"Birkenfeld","year":"1958","journal-title":"J Clin Invest"},{"issue":"17","key":"10.1016\/j.amjms.2022.04.021_bib0003","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1001\/jama.2015.13766","article-title":"Trends in Prescription Drug Use Among Adults in the United States From 1999-2012","volume":"314","author":"Kantor","year":"2015","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.amjms.2022.04.021_bib0004","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1159\/000166814","article-title":"Effects of plasma volume expansion on renal salt handling in patients with the nephrotic syndrome","volume":"4","author":"Koomans","year":"1984","journal-title":"Am J Nephrol"},{"issue":"2","key":"10.1016\/j.amjms.2022.04.021_bib0005","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/cpt1978242199","article-title":"Plasma binding and disposition of furosemide in the nephrotic syndrome and in uremia","volume":"24","author":"Rane","year":"1978","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.amjms.2022.04.021_bib0006","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3390\/cells4040622","article-title":"Albumin and furosemide combination for management of edema in nephrotic syndrome: a review of clinical studies","volume":"4","author":"Duffy","year":"2015","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.amjms.2022.04.021_bib0007","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0022-3476(61)80114-5","article-title":"Studies on the pathogenesis of nephrotic edema","volume":"58","author":"Metcoff","year":"1961","journal-title":"J Pediatr"},{"issue":"7520","key":"10.1016\/j.amjms.2022.04.021_bib0008","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/S0140-6736(67)92234-9","article-title":"Changes in blood-volume produced by treatment in the nephrotic syndrome","volume":"290","author":"Garnett","year":"1967","journal-title":"Lancet"},{"issue":"2_Part_1","key":"10.1016\/j.amjms.2022.04.021_bib0009","doi-asserted-by":"crossref","first-page":"242","DOI":"10.7326\/0003-4819-60-2-242","article-title":"Hypovolemic shock and hypotension as a complication in the nephrotic syndrome","volume":"60","author":"Yamauchi","year":"1964","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.amjms.2022.04.021_bib0010","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/0002-9343(79)90782-4","article-title":"Observations on edema formation in the nephrotic syndrome in adults with minimal lesions","volume":"67","author":"Dorhout Mees","year":"1979","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.amjms.2022.04.021_bib0011","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000183302","article-title":"Plasma and blood volumes in patients with the nephrotic syndrome","volume":"38","author":"Geers","year":"1984","journal-title":"Nephron"},{"issue":"2","key":"10.1016\/j.amjms.2022.04.021_bib0012","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1681\/ASN.2008040364","article-title":"Plasmin in nephrotic urine activates the epithelial sodium channel","volume":"20","author":"Svenningsen","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"4 Suppl","key":"10.1016\/j.amjms.2022.04.021_bib0013","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1172\/JCI102935","article-title":"A study of the mechanisms of edema formation in patients with the nephrotic syndrome 1","volume":"33","author":"Eder","year":"1954","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.amjms.2022.04.021_bib0014","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/ki.1984.176","article-title":"Functional relationships in the nephrotic syndrome","volume":"26","author":"Geers","year":"1984","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.amjms.2022.04.021_bib0015","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF00606681","article-title":"Pharmacokinetics of furosemide in anephric patients and in normal subjects","volume":"13","author":"Andreasen","year":"1978","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.amjms.2022.04.021_bib0016","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/bdd.2510070602","article-title":"Pharmacokinetics of the thiazide diuretics","volume":"7","author":"Welling","year":"1986","journal-title":"Biopharm Drug Dispos"},{"issue":"2","key":"10.1016\/j.amjms.2022.04.021_bib0017","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/cpt1974162322","article-title":"Pharmacokinetics of metolazone in normal subjects and in patients with cardiac or renal failure","volume":"16","author":"Tilstone","year":"1974","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.amjms.2022.04.021_bib0018","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/ki.1987.192","article-title":"Mechanism of furosemide resistance in analbuminemic rats and hypoalbuminemic patients","volume":"32","author":"Inoue","year":"1987","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.amjms.2022.04.021_bib0019","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/cpt1974156588","article-title":"Pharmacokinetics of furosemide in normal subjects and functionally anephric patients","volume":"15","author":"Cutler","year":"1974","journal-title":"Clin Pharmacol Ther"},{"issue":"12","key":"10.1016\/j.amjms.2022.04.021_bib0020","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.2215\/CJN.07400715","article-title":"Acid-base homeostasis","volume":"10","author":"Lee Hamm","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.amjms.2022.04.021_bib0021","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/ki.1987.141","article-title":"Effect of acetazolamide on renal metabolism and ammoniagenesis in the dog","volume":"31","author":"Gougoux","year":"1987","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.amjms.2022.04.021_bib0022","article-title":"Effect of acetazolamide on bicarbonate reabsorption in the proximal tubule of the rat","volume":"6","author":"Cogan","year":"1979","journal-title":"Am J Physiol - Ren Fluid Electrolyte Physiol"},{"issue":"2","key":"10.1016\/j.amjms.2022.04.021_bib0023","doi-asserted-by":"crossref","DOI":"10.1152\/ajprenal.00154.2015","article-title":"Furosemide-induced urinary acidification is caused by pronounced H+ secretion in the thick ascending limb","volume":"309","author":"de Bruijn","year":"2015","journal-title":"Am J Physiol - Ren Physiol"},{"issue":"10","key":"10.1016\/j.amjms.2022.04.021_bib0024","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1038\/sj.ki.5001851","article-title":"The connecting tubule is the main site of the furosemide-induced urinary acidification by the vacuolar H+-ATPase","volume":"70","author":"Kovacikova","year":"2006","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.amjms.2022.04.021_bib0025","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1152\/ajprenal.1983.245.4.F425","article-title":"On the generation, maintenance, and correction of metabolic alkalosis","volume":"14","author":"Jacobson","year":"1983","journal-title":"Am J Physiol - Ren Fluid Electrolyte Physiol"},{"issue":"6","key":"10.1016\/j.amjms.2022.04.021_bib0026","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1038\/ki.1987.150","article-title":"Dietary NaCl determines severity of potassium depletion-induced metabolic alkalosis","volume":"31","author":"Hernandez","year":"1987","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.amjms.2022.04.021_bib0027","article-title":"Pathogenesis of renal hyperchloremic acidosis resulting from dietary potassium restriction in the dog: Role of aldosterone","volume":"7","author":"Hulter","year":"1980","journal-title":"Am J Physiol - Ren Fluid Electrolyte Physiol"},{"issue":"3","key":"10.1016\/j.amjms.2022.04.021_bib0028","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/ki.1972.86","article-title":"The effect of acute potassium depletion on muscle cell pH in vitro","volume":"2","author":"Adler","year":"1972","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.amjms.2022.04.021_bib0029","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/ki.1977.61","article-title":"Potassium and intracellular pH","volume":"11","author":"Adler","year":"1977","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.amjms.2022.04.021_bib0030","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1053\/j.ajkd.2011.06.004","article-title":"Pathophysiology of metabolic alkalosis: A new classification based on the centrality of stimulated collecting duct ion transport","volume":"58","author":"Gennari","year":"2011","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.amjms.2022.04.021_bib0031","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1172\/JCI102769","article-title":"The effect of potassium in nephrectomized rats with hypokalemic alkalosis","volume":"32","author":"Orloff","year":"1953","journal-title":"J Clin Invest"},{"issue":"6701","key":"10.1016\/j.amjms.2022.04.021_bib0032","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0140-6736(52)91463-3","article-title":"Experimental potassium depletion in man","volume":"259","author":"Black","year":"1952","journal-title":"Lancet"},{"issue":"552","key":"10.1016\/j.amjms.2022.04.021_bib0033","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1136\/pgmj.47.552.644","article-title":"The use of amiloride hydrochloride in the correction of hypokalaemic alkalosis induced by diuretics","volume":"47","author":"Antcliff","year":"1971","journal-title":"Postgrad Med J"},{"issue":"4","key":"10.1016\/j.amjms.2022.04.021_bib0034","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2125.1993.tb04153.x","article-title":"A comparison of the potassium and magnesium-sparing properties of amiloride and spironolactone in diuretic-treated normal subjects","volume":"35","author":"Murdoch","year":"1993","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.amjms.2022.04.021_bib0035","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3109\/10641963.2012.721843","article-title":"Effect of amiloride and spironolactone on renal tubular function and central blood pressure in patients with arterial hypertension during baseline conditions and after furosemide: A double-blinded, randomized, placebo-controlled crossover trial","volume":"35","author":"Matthesen","year":"2013","journal-title":"Clin Exp Hypertens"},{"issue":"20","key":"10.1016\/j.amjms.2022.04.021_bib0052","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1056\/NEJMoa065181","article-title":"Tolvaptan, a selective oral vasopressin V 2 -receptor antagonist, for hyponatremia","volume":"355","author":"Schrier","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjms.2022.04.021_bib0053","unstructured":"Tolvaptan. Accessed May 5, 2021. https:\/\/www-micromedexsolutions-com.foyer.swmed.edu\/micromedex2\/librarian\/CS\/535743\/ND_PR\/evidencexpert\/ND_P\/evidencexpert\/DUPLICATIONSHIELDSYNC\/37E1D4\/ND_PG\/ evidencexpert\/ND_B\/evidencexpert\/ND_AppProduct\/evidencexpert\/ND_T\/evidencexpert\/PFActionId\/redboo"},{"key":"10.1016\/j.amjms.2022.04.021_bib0054","unstructured":"FDA Drug Safety Communication: FDA limits duration and usage of Samsca (tolvaptan) due to possible liver injury leading to organ transplant or death | FDA. Accessed February 6, 2021. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-limits-duration-and-usage-samsca-tolvaptan-due-possible-liver"},{"key":"10.1016\/j.amjms.2022.04.021_bib0036","unstructured":"FDA. Sodium Thiosulfate. Highlights of Prescribing Information. Accessed May 4, 2021. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/203923s000lbl.pdf"},{"issue":"6","key":"10.1016\/j.amjms.2022.04.021_bib0037","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1053\/j.ajkd.2004.03.018","article-title":"Successful treatment of calciphylaxis with intravenous sodium thiosulfate","volume":"43","author":"Cicone","year":"2004","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1016\/j.amjms.2022.04.021_bib0038","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/MNH.0000000000000520","article-title":"Revisiting therapeutic options for calciphylaxis","volume":"28","author":"Seethapathy","year":"2019","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"6","key":"10.1016\/j.amjms.2022.04.021_bib0039","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1681\/ASN.2008070754","article-title":"Thiosulfate reduces calcium phosphate nephrolithiasis","volume":"20","author":"Asplin","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.amjms.2022.04.021_bib0040","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1525-139X.2005.00082.x","article-title":"Long-term intravenous sodium thiosulfate in the treatment of a patient with calciphylaxis","volume":"18","author":"Brucculeri","year":"2005","journal-title":"Semin Dial"},{"issue":"3","key":"10.1016\/j.amjms.2022.04.021_bib0041","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1053\/j.ajkd.2016.02.040","article-title":"Sodium Thiosulfate and the Anion Gap in Patients Treated by Hemodialysis","volume":"68","author":"Hundemer","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1016\/j.amjms.2022.04.021_bib0042","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s13181-013-0305-z","article-title":"Severe Anion Gap Acidosis Associated with Intravenous Sodium Thiosulfate Administration","volume":"9","author":"Mao","year":"2013","journal-title":"J Med Toxicol"},{"issue":"4","key":"10.1016\/j.amjms.2022.04.021_bib0043","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1371\/journal.pone.0060380","article-title":"A Pilot Study of the Effect of Sodium Thiosulfate on Urinary Lithogenicity and Associated Metabolic Acid Load in Non-Stone Formers and Stone Formers with Hypercalciuria","volume":"8","author":"Okonkwo","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.amjms.2022.04.021_bib0044","article-title":"Diagnosis, evaluation, and treatment of hyponatremia: Expert panel recommendations","volume":"126","author":"Verbalis","year":"2013","journal-title":"Am J Med"},{"issue":"9","key":"10.1016\/j.amjms.2022.04.021_bib0045","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1172\/JCI103712","article-title":"Interrelations between serum sodium concentration, serum osmolarity and total exchangeable sodium, total exchangeable potassium and total body water","volume":"37","author":"Edelman","year":"1958","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.amjms.2022.04.021_bib0046","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1172\/JCI102952","article-title":"The effect of potassium chloride on hyponatremia","volume":"33","author":"Laragh","year":"1954","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.amjms.2022.04.021_bib0047","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/ki.1973.5","article-title":"Effect of furosemide on free water excretion in edematous patients with hyponatremia","volume":"3","author":"Schrier","year":"1973","journal-title":"Kidney Int"},{"key":"10.1016\/j.amjms.2022.04.021_bib0048","doi-asserted-by":"crossref","unstructured":"Errors in table 1. Correction. Kidney Int. 1973;3(6):417. https:\/\/doi.org\/10.1038\/ki.1973.69","DOI":"10.1038\/ki.1973.69"},{"issue":"9","key":"10.1016\/j.amjms.2022.04.021_bib0049","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1172\/JCI105252","article-title":"The site of action of furosemide and other sulfonamide diuretics in the dog","volume":"44","author":"Suki","year":"1965","journal-title":"J Clin Invest"},{"issue":"12","key":"10.1016\/j.amjms.2022.04.021_bib0050","first-page":"1513","article-title":"Adverse biochemical and clinical consequences of furosemide administration","volume":"118","author":"Spino","year":"1978","journal-title":"Can Med Assoc J"},{"issue":"8","key":"10.1016\/j.amjms.2022.04.021_bib0051","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.jacc.2005.11.071","article-title":"Aquaretic effect of lixivaptan, an oral, non-peptide, selective V2 receptor vasopressin antagonist, in New York Heart Association functional class II and III chronic heart failure patients","volume":"47","author":"Abraham","year":"2006","journal-title":"J Am Coll Cardiol"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962922001823?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962922001823?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:41:25Z","timestamp":1757702485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962922001823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0002962922001823"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2022.04.021","relation":{},"ISSN":["0002-9629"],"issn-type":[{"type":"print","value":"0002-9629"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenges in diuretic therapy: A case-based discussion","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2022.04.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}